Potential therapy of multidrugresistant and extremely drug-resistant tuberculosis with thioridazine

Leonard Amaral, J Molnar , J Molnar

Research output: Contribution to journalArticle

Abstract

Multidrug-resistant tuberculosis (MDRTB) infections that continue to increase in frequency globally have progressed to become extremely drug-resistant tuberculosis (XDRTB). The therapeutic problems associated with MDRTB pale in comparison to those for XDRTB where mortality is high. This mini-review highlights the evidence that supports the use of the phenothiazine neuroleptic thioridazine for the therapy of XDRTB. Although thioridazine does produce some serious side-effects, the poor prognosis associated with an XDRTB infection of a patient that presents with AIDS merits that the use of thioridazine for therapy of XDRTB is seriously considered. A recommended protocol is presented.
Original languageEnglish
JournalIn Vivo
Volume26
Issue number2
Publication statusPublished - 2012

Fingerprint Dive into the research topics of 'Potential therapy of multidrugresistant and extremely drug-resistant tuberculosis with thioridazine'. Together they form a unique fingerprint.

Cite this